 | • レポートコード：MRC2304I0180 • 出版社/出版日：Persistence Market Research / 2023年2月23日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥735,000 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,140,000 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,590,000 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の痛み止めパッチ市場について調査・分析を行い、市場の現状と今後の展望を整理しています。本書は、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症危機分析、価格分析、価値分析・予測、製品別（非ステロイド性抗炎症薬パッチ、ケトロプロフェンパッチ、ジクロフェナクパッチ、フルルビプロフェンパッチ、その他）分析、適応症別（月経痛、整形的疼痛、神経障害性疼痛、心血管性疼痛、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成で掲載しています。また、Viatris, Inc. (Mylan)、Obalon Therapeutics, Inc.、Johnson & Johnson Services, Inc.、Teva Pharmaceutical Industries Ltd.、Sanofi S.A.、Hisamitsu Pharmaceutical Co., Inc.、GlaxoSmithKline Plc.、Novartis AG、Nichiban Co., Ltd.、Teikoku Seiyaku Co, Ltd.などの企業情報が含まれています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症危機分析 ・価格分析 ・価値分析・予測 ・世界の痛み止めパッチ市場規模：製品別 - 非ステロイド性抗炎症薬パッチの市場規模 - ケトロプロフェンパッチの市場規模 - ジクロフェナクパッチの市場規模 - フルルビプロフェンパッチの市場規模 - その他製品の市場規模 ・世界の痛み止めパッチ市場規模：適応症別 - 月経痛における市場規模 - 整形的疼痛における市場規模 - 神経障害性疼痛における市場規模 - 心血管性疼痛における市場規模 - その他適応症における市場規模 ・世界の痛み止めパッチ市場規模：流通チャネル別 - 病院薬局チャネルの市場規模 - 小売薬局チャネルの市場規模 - オンライン薬局チャネルの市場規模 ・世界の痛み止めパッチ市場規模：地域別 - 北米の痛み止めパッチ市場規模 - 中南米の痛み止めパッチ市場規模 - ヨーロッパの痛み止めパッチ市場規模 - 東アジアの痛み止めパッチ市場規模 - 南アジアの痛み止めパッチ市場規模 - 南オセアニアの痛み止めパッチ市場規模 - 中東・アフリカの痛み止めパッチ市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Pain Relief Patches Market – Report Scope
A recent market study published by Persistence Market Research on the pain relief patches market offers a global industry analysis for 2017 to 2021 and an opportunity assessment for 2022 to 2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the pain relief patches market, growth prospects of the market are obtained with maximum precision.
The report features unique and salient factors that may make a huge impact on the development of the pain relief patches market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.
The report provides detailed information about the current and future growth prospects of the pain relief patches market in the most comprehensive way for a better understanding of readers.
Key Market Segments
This study on the pain relief patches market offers information divided into four important segments — product, indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Non-Steroidal Anti-inflammatory Drug Patches
Ketroprofen Patches
Diclofenac Patches
Flurbiprofen Patches
Piroxicam Patches
Opioid Patches
Fentanyl Patches
Buprenorphine Patches
Local Anaesthetic Patches
Nitro-glycerine Patches
Capsaicin Patches
Lidocaine Patches
Indication
Menstrual Cramps
Orthopaedic Pain
Neuropathic Pain
Post-Operative Pain
Cardiovascular Pain
Others
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA
Chapter 01 – Executive Summary
The report commences with the executive summary of the pain relief patches market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US million) estimates of the leading segments of the pain relief patches market as well as the key trends influencing the market.
Chapter 02 – Market Overview
Readers can find detailed taxonomy and product definition/scope/limitations, inclusions, and exclusions of the pain relief patches market in this chapter, which helps readers, understand basic information about the pain relief patches market.
Chapter 03 – Key Market Trends
This section highlights the key trends influencing the pain relief patches market, which will help readers in understanding the current trends and their impact on market growth.
Chapter 04 – Key Success Factors
This section highlights the market context impacting the pain relief patches market, which will help readers in understanding key promotional strategies adopted by key player, product adoption and usage analysis, technology assessment, regulatory scenario, value chain analysis, Porter’s analysis, PESTLE analysis that is expected to create a positive impact on the growth of the pain relief patches market during the forecast period.
Chapter 05 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the pain relief patches market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the pain relief patches market, which include the drivers, restraints, and opportunity analysis.
Chapter 06 – COVID-19 Crisis Analysis
This section provides the current and expected impact of COVID-19 on the pain relief patches market.
Chapter 07 – Global Pain Relief Patches Market- Pricing Analysis
This section highlights the pricing analysis influencing the pain relief patches market, which will help readers in understanding pricing analyses that are expected to create a positive impact on the growth of the pain relief patches market during the forecast period.
Chapter 08 – Global Market Value US$ Mn Analysis 2017–2021 and Forecast, 2022–2032
This section explains the global market value or size analysis and forecasts for the pain relief patches market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022-2032).
Chapter 9 – Global Market analysis 2017-2021 and Forecast 2022-2032, By Product
Based on product, the pain relief patches market is segmented into (non-steroidal anti-inflammatory drug patches (ketroprofen patches, diclofenac patches, flurbiprofen patches, piroxicam patches) opioid patches (fentanyl patches, buprenorphine), local anaesthetic patches (nitro-glycerine patches, capsaicin patches, lidocaine patches)). In this chapter, readers can find information about a detailed analysis of the market by different products available in the pain relief patches market and their growth over the forecast period.
Chapter 10 – Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication
Based on indication, the pain relief patches market is segmented into (menstrual cramps, orthopaedic pain, neuropathic pain, post-operative pain, cardiovascular pains, and others), in this chapter, readers can find information about a detailed analysis of the market by different indications available in the pain relief patches market and their growth over the forecast period.
Chapter 11 – Global Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Based on the distribution channel, the pain relief patches market is segmented into (hospital pharmacies, retail pharmacies, and online pharmacies). In this chapter, readers can find information about a detailed analysis of the market by different distribution channel available in the pain relief patches market and their growth over the forecast period.
Chapter 12 – Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
This chapter explains how the pain relief patches market will grow across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania and the Middle East and Africa (MEA).
Chapter 13 – North America Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the North American pain relief patches market along with a country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product, indication, distribution channel and country of the pain relief patches market in the North American region.
Chapter 14 – Latin America Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes the growth prospects of the pain relief patches market in leading countries such as Brazil, Mexico, Argentina and the rest of Latin America. Readers can find thorough information about the growth parameters based on product, indication, distribution channel and country in the Latin America pain relief patches market during 2022-2032.
Chapter 15 – Europe Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes the growth prospects of the pain relief patches market based on the development of the new product, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX and the Rest of Europe are included in this chapter.
Chapter 16 – South Asia Market Analysis 2017-2021 and Forecast 2022-2032
India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the pain relief patches market. Also, in this chapter, readers can find thorough information about the growth parameters of the South Asia pain relief patches market growth over the forecast period.
Chapter 17 – East Asia Market Analysis 2017-2021 and Forecast 2022-2032
China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia pain relief patches market. Also, in this chapter, readers can find thorough information about the growth parameters of the East Asia pain relief patches market through 2032.
Chapter 18 – Oceania Market Analysis 2017-2021 and Forecast 2022-2032
This chapter consists of important parameters that have a huge impact on the growth of the pain relief patches market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania pain relief patches market.
Chapter 19 – Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032
This chapter provides information on how the pain relief patches market will grow in the major countries in the MEA region, such as GCC Countries, Türkiye, North Africa, South Africa and the rest of MEA during 2022-2032.
Chapter 20 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the pain relief patches market.
Chapter 21 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the pain relief patches market including a company overview, revenue shares, strategic overview, and recent company developments. Some of the major market players featured in the report are Viatris, Inc. (Mylan), Johnson & Johnson Services, Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Hisamitsu Pharmaceutical Co., Inc., GlaxoSmithKline Plc., Novartis AG, Nichiban Co., Ltd., Teikoku Seiyaku Co, Ltd., Mentholatum Company., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Pfizer Inc., Allergan Plc (Actavis), Endo International plc, Mylan N.V., Corium, Inc, and Agile Therapeutics Inc.
Chapter 22 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.
Chapter 23 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the pain relief patches market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Key Promotional Strategies, By Key Player
4.2. Product Adoption/Usage Analysis
4.3. Technology Assessment
4.4. Regulatory Scenario
4.5. Value Chain Analysis
4.6. Porter’s Analysis
4.7. PESTEL analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Market Outlook
5.1.3. Per Capita Healthcare Spending Outlook
5.2. Forecast Factors – Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Product Adoption Rate and Demand
5.2.3. New Product Launches
5.2.4. Increase in Demand for Non-invasive Pain Management Treatment
5.2.5. Changing Regulatory Dynamics
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Indication
6.1.3. By Distribution Channel
6.1.4. By Region
6.2. 2021 Market Scenario
7. Global Market Pricing Analysis
7.1. Regional Pricing Analysis, By Product Type
7.2. Global Average Pricing Analysis Benchmark
7.3. Pricing Assumptions
8. Global Market Value US$ Mn Analysis 2017–2021 and Forecast, 2022–2032
8.1. Historical Market Value (US$ Mn) Analysis, 2017–2021
8.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2022–2032
8.2.1. Y-o-Y Growth Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Market Analysis 2017–2021 and Forecast 2022–2032, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis, 2017–2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032
9.3.1. Non-Steroidal Anti- Inflammatory Drug Patches
9.3.2. Ketroprofen Patches
9.3.3. Diclofenac Patches
9.3.4. Flurbiprofen Patches
9.3.5. Piroxicam Patches
9.3.6. Opioid Patches
9.3.7. Fentanyl Patches
9.3.8. Buprenorphine
9.3.9. Local Anaesthetic Patches
9.3.10. Nitro-glycerin Patches
9.3.11. Capsaicin Patches
9.3.12. Lidocaine Patches
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2017–2021 and Forecast 2022–2032, By Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis, 2017–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032
10.3.1. Menstrual Cramps
10.3.2. Orthopedic Pain
10.3.3. Neuropathic Pain
10.3.4. Post-Operative Pain
10.3.5. Cardiovascular Pain
10.3.6. Others
10.4. Market Attractiveness Analysis By Indication
11. Global Market analysis 2017–2021 and forecast 2022–2032, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, 2017–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022–2032
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Market Analysis 2017–2021 and Forecast 2022–2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis, 2017–2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017–2021 and Forecast 2022–2032
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2021
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2022–2032
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Indication
13.4.4. By Distribution Channel
13.5. Market Trends
13.6. Key Market Participants – Intensity Mapping
13.7. Drivers and Restraints – Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. U.S. Market
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Indication
13.8.1.2.3. By Distribution Channel
13.8.2. Canada Market
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Indication
13.8.2.2.3. By Distribution Channel
14. Latin America Market Analysis 2017–2021 and Forecast 2022–2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Rest of Latin America
14.3.2. By Product
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Indication
14.4.4. By Distribution Channel
14.5. Market Trends
14.6. Key Market Participants – Intensity Mapping
14.7. Drivers and Restraints – Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. Brazil Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Indication
14.8.1.2.3. By Distribution Channel
14.8.2. Argentina Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Indication
14.8.2.2.3. By Distribution Channel
14.8.3. Mexico Market
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Indication
14.8.3.2.3. By Distribution Channel
15. Europe Market Analysis 2017–2021 and Forecast 2022–2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Indication
15.4.4. By Distribution Channel
15.5. Market Trends
15.6. Key Market Participants – Intensity Mapping
15.7. Drivers and Restraints – Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Germany Market
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Indication
15.8.1.2.3. By Distribution Channel
15.8.2. France Market
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Indication
15.8.2.2.3. By Distribution Channel
15.8.3. Italy Market
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Indication
15.8.3.2.3. By Distribution Channel
15.8.4. Spain Market
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Indication
15.8.4.2.3. By Distribution Channel
15.8.5. U.K. Market
15.8.5.1. Introduction
15.8.5.2. Market Analysis and Forecast by Market Taxonomy
15.8.5.2.1. By Product
15.8.5.2.2. By Indication
15.8.5.2.3. By Distribution Channel
15.8.6. Benelux Union Market
15.8.6.1. Introduction
15.8.6.2. Market Analysis and Forecast by Market Taxonomy
15.8.6.2.1. By Product
15.8.6.2.2. By Indication
15.8.6.2.3. By Distribution Channel
15.8.7. Russia Market
15.8.7.1. Introduction
15.8.7.2. Market Analysis and Forecast by Market Taxonomy
15.8.7.2.1. By Product
15.8.7.2.2. By Indication
15.8.7.2.3. By Distribution Channel
16. South Market Analysis 2017–2021 and Forecast 2022–2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Indication
16.4.4. By Distribution Channel
16.5. Market Trends
16.6. Key Market Participants – Intensity Mapping
16.7. Drivers and Restraints – Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. India Market
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Indication
16.8.1.2.3. By Distribution Channel
16.8.2. Indonesia Market
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Indication
16.8.2.2.3. By Distribution Channel
16.8.3. Thailand Market
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Indication
16.8.3.2.3. By Distribution Channel
16.8.4. Malaysia Market
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Indication
16.8.4.2.3. By Distribution Channel
17. East Market Analysis 2017–2021 and Forecast 2022–2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Indication
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Indication
17.4.4. By Distribution Channel
17.5. Market Trends
17.6. Key Market Participants – Intensity Mapping
17.7. Drivers and Restraints – Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Market
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Indication
17.8.1.2.3. By Distribution Channel
17.8.2. Japan Market
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Indication
17.8.2.2.3. By Distribution Channel
17.8.3. South Korea Market
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Indication
17.8.3.2.3. By Distribution Channel
18. Oceania Market Analysis 2017–2021 and Forecast 2022–2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Indication
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Indication
18.4.4. By Distribution Channel
18.5. Market Trends
18.6. Key Market Participants – Intensity Mapping
18.7. Drivers and Restraints – Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. Australia Market
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Indication
18.8.1.2.3. By Distribution Channel
18.8.2. New Zealand Market
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Indication
18.8.2.2.3. By Distribution Channel
19. Middle East and Africa (MEA) Market Analysis 2017–2021 and Forecast 2022–2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021
19.3. Current and Future Market Size (US$ Mn)Analysis and Forecast By Market Taxonomy, 2022–2032
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. North Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Product
19.3.3. By Indication
19.3.4. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Indication
19.4.4. By Distribution Channel
19.5. Market Trends
19.6. Key Market Participants – Intensity Mapping
19.7. Drivers and Restraints – Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. GCC Countries Market
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Indication
19.8.1.2.3. By Distribution Channel
19.8.2. Türkiye Market
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Indication
19.8.2.2.3. By Distribution Channel
19.8.3. South Africa Market
19.8.3.1. Introduction
19.8.3.2. Market Analysis and Forecast by Market Taxonomy
19.8.3.2.1. By Product
19.8.3.2.2. By Indication
19.8.3.2.3. By Distribution Channel
19.8.4. North Africa Market
19.8.4.1. Introduction
19.8.4.2. Market Analysis and Forecast by Market Taxonomy
19.8.4.2.1. By Product
19.8.4.2.2. By Indication
19.8.4.2.3. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Technology Footprint
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Viatris, Inc. (Mylan)
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. SWOT Analysis
21.3.1.5. Sales Footprint
21.3.1.6. Key Developments
21.3.1.7. Strategy Overview
21.3.2. Obalon Therapeutics, Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Key Financials
21.3.2.4. SWOT Analysis
21.3.2.5. Sales Footprint
21.3.2.6. Key Developments
21.3.2.7. Strategy Overview
21.3.3. Johnson & Johnson Services, Inc.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Key Financials
21.3.3.4. SWOT Analysis
21.3.3.5. Sales Footprint
21.3.3.6. Key Developments
21.3.3.7. Strategy Overview
21.3.4. Teva Pharmaceutical Industries Ltd.
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Key Financials
21.3.4.4. SWOT Analysis
21.3.4.5. Sales Footprint
21.3.4.6. Key Developments
21.3.4.7. Strategy Overview
21.3.5. Sanofi S.A.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Key Financials
21.3.5.4. SWOT Analysis
21.3.5.5. Sales Footprint
21.3.5.6. Key Developments
21.3.5.7. Strategy Overview
21.3.6. Hisamitsu Pharmaceutical Co., Inc.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Key Financials
21.3.6.4. SWOT Analysis
21.3.6.5. Sales Footprint
21.3.6.6. Key Developments
21.3.6.7. Strategy Overview
21.3.7. GlaxoSmithKline Plc.
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Key Financials
21.3.7.4. SWOT Analysis
21.3.7.5. Sales Footprint
21.3.7.6. Key Developments
21.3.7.7. Strategy Overview
21.3.8. Novartis AG
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Key Financials
21.3.8.4. SWOT Analysis
21.3.8.5. Sales Footprint
21.3.8.6. Key Developments
21.3.8.7. Strategy Overview
21.3.9. Nichiban Co., Ltd.
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Key Financials
21.3.9.4. SWOT Analysis
21.3.9.5. Sales Footprint
21.3.9.6. Key Developments
21.3.9.7. Strategy Overview
21.3.10. Teikoku Seiyaku Co, Ltd.
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Key Financials
21.3.10.4. SWOT Analysis
21.3.10.5. Sales Footprint
21.3.10.6. Key Developments
21.3.10.7. Strategy Overview
21.3.11. Mentholatum Company.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Key Financials
21.3.11.4. SWOT Analysis
21.3.11.5. Sales Footprint
21.3.11.6. Key Developments
21.3.11.7. Strategy Overview
21.3.12. Purdue Pharma L.P.
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Key Financials
21.3.12.4. SWOT Analysis
21.3.12.5. Sales Footprint
21.3.12.6. Key Developments
21.3.12.7. Strategy Overview
21.3.13. West-Ward Pharmaceuticals Corporation
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Key Financials
21.3.13.4. SWOT Analysis
21.3.13.5. Sales Footprint
21.3.13.6. Key Developments
21.3.13.7. Strategy Overview
21.3.14. Pfizer, Inc
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Key Financials
21.3.14.4. SWOT Analysis
21.3.14.5. Sales Footprint
21.3.14.6. Key Developments
21.3.14.7. Strategy Overview
21.3.15. Allergan Plc (Actavis)
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Key Financials
21.3.15.4. SWOT Analysis
21.3.15.5. Sales Footprint
21.3.15.6. Key Developments
21.3.15.7. Strategy Overview
21.3.16. Endo International plc,
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Key Financials
21.3.16.4. SWOT Analysis
21.3.16.5. Sales Footprint
21.3.16.6. Key Developments
21.3.16.7. Strategy Overview
21.3.17. Mylan N.V.
21.3.17.1. Overview
21.3.17.2. Product Portfolio
21.3.17.3. Key Financials
21.3.17.4. SWOT Analysis
21.3.17.5. Sales Footprint
21.3.17.6. Key Developments
21.3.17.7. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology